|
| << previous | next >> |
Journal description
All volumes of the corresponding journal
All issues of the corresponding volume
All articles of the corresponding issues
Details for article 4 of 22 found articles
| Title: |
A phase II study of intravenous exatecan mesylate (DX-8951f) administered daily for 5 days every 3 weeks to patients with advanced ovarian, tubal or peritoneal cancer resistant to platinum, taxane and topotecan |
| Author: |
Verschraegen, Claire F. Kudelka, Andrzej P. Hu, Wei Vincent, Monique Kavanagh, John J. Loyer, Evelyne Bastien, Luc Duggal, A. Jager, R. De |
| Appeared in: |
Cancer, chemotherapy and pharmacology |
| Paging: | Volume 53 (2003) nr. 1 pages 1-7 |
| Year: |
2003 |
| Contents: | |
| Publisher: |
Springer-Verlag, Berlin/Heidelberg |
| Source file: |
Elektronische Wetenschappelijke Tijdschriften |
Details for article 4 of 22 found articles
| << previous | next >> |